Sarcoma: open trials in Mexico

• NCT04557449

  Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors

  Trial Treatment · Phase 1/2 · Pfizer

  COI Centro Oncologico Internacional S.A.P.I. de C.V., Mexico City · INCAN, Mexico City · Hospital MAC Periferico Sur, Mexico City · Hospital Universitario Dr. Jose Eleuterio González, Monterrey · Hospital Reforma, Oaxaca City · Oaxaca Site Management Organization, Oaxaca City

  Registry updated 2026-10-28

• NCT06345729

  A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)

  Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC

  Instituto Nacional de Cancerologia. ( Site 0608), México · Arké SMO S.A. de C.V. ( Site 0602), Mexico City · Hospital Universitario "Dr. Jose Eleuterio Gonzalez"-Hematologia and Oncologia ( Site 0600), Monterrey · Oaxaca Site Management Organization S.C. ( Site 0603), Oaxaca City

  Registry updated 2026-10-26

• NCT05797662

  A Study of Propranolol to Treat Kaposi Sarcoma

  Trial Treatment · Phase 2 · AIDS Malignancy Consortium

  Instituto Nacional de Cancerologia, Mexico City

  Registry updated 2026-10-05

• NCT04181970

  Observational Study, for Quality Assessment, of Sarcoma in European and Latin American Multidisciplinary NETWORK

  Research · Grupo Espanol de Investigacion en Sarcomas

  Instituto Nacional de Cancerologia, Mexico City

  Registry updated 2025-03-21

All Sarcoma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error